The ZOLL LifeVest® team is "going red" for Heart Month in February 2026 in support of the American Heart Association and ...
CHELMSFORD, Mass., January 12, 2026--(BUSINESS WIRE)--ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the LifeVest® wearable cardioverter ...
LifeVest Wearable Defibrillator Prescribed by Physicians at All U.S. News and World Report’s #1 Ranked “Top Metro” Hospitals The LifeVest is worn by patients at risk for SCA, providing protection ...
ZOLL is a global leader in medical devices and related software and diagnostic tools used in critical care. As part of its growth strategy, Asahi Kasei positions Critical Care as a First Priority ...
A phase 3 trial of Zoll Medical’s LifeVest has missed its primary endpoint. The study found that people who started using the wearable defibrillator the week after they had a heart attack were as ...
CHELMSFORD, Mass.--(BUSINESS WIRE)--ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that the Centers for Medicare and ...
CHELMSFORD, Mass.--(BUSINESS WIRE)-- ZOLL Medical Corporation (NasdaqGS: ZOLL), a manufacturer of medical devices and related software solutions, announced today that more than 50,000 patients at high ...
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced that the LifeVest® wearable cardioverter defibrillator (WCD) saved 143 patients between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results